VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma

被引:48
作者
Linehan, W. Marston [1 ]
Rubin, Jeffrey S. [2 ]
Bottaro, Donald P. [1 ]
机构
[1] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
关键词
VHL; HIF; Oncogenesis; HGF; beta-Catenin; Renal cell carcinoma; HEPATOCYTE GROWTH-FACTOR; TUMOR-SUPPRESSOR GENE; BETA-CATENIN; EXPRESSION; THERAPEUTICS; DISEASE; CANCER; HYPOXIA;
D O I
10.1016/j.biocel.2008.09.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Loss of von Hippel-Lindau tumor suppressor gene function occurs in familial and most sporadic clear cell renal cell carcinoma, resulting in the aberrant expression of genes that control cell proliferation, metabolism, invasion and angiogenesis. The molecular mechanisms by which loss of function leads to tumorigenesis are not yet fully defined. The von Hippel-Lindau gene product is part of an ubiquitin ligase complex that targets hypoxia inducible factors for polyubiquitination and proteasomal degradation, linking hypoxia response genes to renal cell carcinoma oncogenesis. Loss von Hippel-Lindau gene function also promotes cell invasiveness in response to hepatocyte growth factor, an important regulator of kidney development and renal homeostasis. Increased cell invasiveness is mediated by another ubiquitin ligase target with relevance to the molecular pathogenesis of renal cell carcinoma: P-catenin. This discovery and other recent insights into kidney cancer oncogenesis implicate convergent developmental and homeostatic signaling pathways in tumorigenesis, tumor invasiveness and metastasis. Published by Elsevier Ltd.
引用
收藏
页码:753 / 756
页数:4
相关论文
共 22 条
[1]   Expression of hypoxia-inducible transcription factors in developing human and rat kidneys [J].
Bernhardt, WM ;
Schmitt, R ;
Rosenberger, C ;
Münchenhagen, PM ;
Gröne, HJ ;
Frei, U ;
Warnecke, C ;
Bachmann, S ;
Wiesener, MS ;
Willam, C ;
Eckardt, KU .
KIDNEY INTERNATIONAL, 2006, 69 (01) :114-122
[2]   Met, metastasis, motility and more [J].
Birchmeier, C ;
Birchmeier, W ;
Gherardi, E ;
Vande Woude, GF .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (12) :915-925
[3]   Essential role of BCL9-2 in the switch between β-catenin's adhesive and transcriptional functions [J].
Brembeck, FH ;
Schwarz-Romond, T ;
Bakkers, J ;
Wilhelm, S ;
Hammerschmidt, M ;
Birchmeier, W .
GENES & DEVELOPMENT, 2004, 18 (18) :2225-2230
[4]   Wnt/β-catenin signaling in development and disease [J].
Clevers, Hans .
CELL, 2006, 127 (03) :469-480
[5]   Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma [J].
Dahl, E. ;
Wiesmann, F. ;
Woenckhaus, M. ;
Stoehr, R. ;
Wild, P. J. ;
Veeck, J. ;
Knuechell, R. ;
Klopocki, E. ;
Sauter, G. ;
Simon, R. ;
Wieland, W. F. ;
Walter, B. ;
Denzinger, S. ;
Hartmann, A. ;
Hammerschmied, C. G. .
ONCOGENE, 2007, 26 (38) :5680-5691
[6]   The cellular basis of kidney development [J].
Dressler, Gregory R. .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2006, 22 :509-529
[7]   Wnt signaling in renal cancer [J].
Guillen-Ahlers, Hector .
CURRENT DRUG TARGETS, 2008, 9 (07) :591-600
[8]   Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma [J].
Gumz, Michelle L. ;
Zou, Hongzhi ;
Kreinest, Pamela A. ;
Childs, April C. ;
Belmonte, Leandra S. ;
LeGrand, Shauna N. ;
Wu, Kevin J. ;
Luxon, Bruce A. ;
Sinha, Mala ;
Parker, Alexander S. ;
Sun, L-Z. ;
Ahlquist, David A. ;
Wood, Christopher G. ;
Copland, John A. .
CLINICAL CANCER RESEARCH, 2007, 13 (16) :4740-4749
[9]   Metanephrogenic mesenchyme-to-epithelium transition induces profound expression changes of ion channels [J].
Huber, SM ;
Braun, GS ;
Segerer, S ;
Veh, RW ;
Horster, MF .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 279 (01) :F65-F76
[10]   Molecular basis of the VHL hereditary cancer syndrome [J].
Kaelin, WG .
NATURE REVIEWS CANCER, 2002, 2 (09) :673-682